Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 493 (TSXV: $KHRN.V) (NYSE: $ACB) (TSX: $ACB.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSX: $RIV.TO)
Delta, Kelowna, BC, November 9, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/110920-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/11091KHRN-ACB-WEED-CGC-RIV.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few public announcements.
Khiron
Life Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF), a vertically integrated cannabis leader with core
operations in Latin America and Europe, announced that it
has entered into an agreement with Canaccord
Genuity Corp., as lead underwriter and sole bookrunner, on behalf of a
syndicate of underwriters, to increase the size of its previously announced
"bought deal" financing from $10,012,500 to $12,600,000. Pursuant to
the amended terms, the Underwriters have agreed to purchase 28,000,000 units of
the Company on a "bought deal" basis, pursuant to a short form
prospectus at a price per Unit of $0.45 for gross proceeds of $12,600,000.
The Company has also granted the
Underwriters an over-allotment option to purchase up to an additional 15% of
the Units at the Issue Price at any time on or prior to the date that is 30
days following the closing of the Offering. If this option is exercised in
full, the Company will receive an additional $1,890,000 in gross proceeds for
total aggregate gross proceeds of $14,490,000.
Each Unit will be comprised of one
common share in the capital of the Company, and one warrant. Each Warrant will
entitle the holder thereof to purchase one Common Share at an exercise price of
$0.75, for a period ending five years from the closing of the Offering.
The Company intends to use the net
proceeds of the Offering to expand the Company's operating capacity and for
working capital requirements and other general corporate purposes.
In connection with the Offering the
Company has agreed to pay the Underwriters a cash commission equal to 6.0% of
the gross proceeds raised from the Offering (including on any exercise of the
Over-Allotment Option), and non-transferable compensation options equal to 6.0%
of the Units sold under the Offering. Each compensation option will be
exercisable at the Issue Price to acquire one Unit for a period of 24 months
following the closing of the Offering.
The closing date of the Offering is
scheduled to be on or about November 26, 2020 and is subject to certain
conditions including, but not limited to, the receipt of all necessary
approvals, including the approval of the TSX Venture Exchange and the
applicable securities regulatory authorities.
Aurora
Cannabis Inc. (NYSE:
ACB)
(TSX:
ACB),
the Canadian company defining the future of cannabinoids worldwide,
today announced its financial and operational results for
the first quarter of fiscal 2021 ended September 30, 2020.
"We continue to take the
necessary steps to execute our plan and transform our business to achieve
sustainable profitability, and ultimately positive cash flow," stated
Miguel Martin, Chief Executive Officer of Aurora Cannabis. "Our Q1 2021
results are transitional but do highlight successes across a number of diverse
profit pools. We remain the leader by revenue in the high-margin Canadian
medical market, our international medical business experienced more than 40%
net revenue growth this quarter, and our CBD brand Reliva is #1 ranked by
Nielsen in the U.S. CBD sector."
"While we are not satisfied
with our past performance in the growing Canadian consumer business, we have a
sense of urgency in the execution of our tactical plan to grow profitable
market share. Our efforts are directed at delivering the highest quality
products, refocusing on our leading premium and ultra-premium brands, better
allocating our sales and marketing spend, and executing key account
partnerships at both the province and retail levels."
"We have also taken action to
improve our liquidity and strengthen our balance sheet. It was a responsible
decision to raise capital using our ATM in today's environment and the cash is
expected to ensure we have the runway needed to compete with our peers.
Cannabis companies are being evaluated on both their business performance and
liquidity and we wanted to ensure that we are addressing both. I remain
confident in Aurora's prospects and it is my utmost priority to secure our
winning future."
Canopy
Growth Corporation (TSX:
WEED) (NYSE:
CGC)
today
announced its financial results for the second quarter fiscal
2021 ended September 30, 2020. All financial
information in this press release is reported in millions of Canadian dollars,
unless otherwise indicated.
"Our renewed strategy of
winning consumer mindshare, along with increased agility and execution, has
resulted in record net revenue for the second quarter and momentum across key
areas of business," said David Klein, CEO.
"Canopy Growth is positioned for continued growth as we establish a
strong leadership position that is showcased through our vast portfolio of
differentiated brands and products – including our industry leading
cannabis-infused beverages."
"We saw another quarter of
improvement in our operating expense ratio while our marketing and R&D
investments are being re-directed to drive sales," added Mike Lee, CFO.
"Importantly, our end-to-end review has identified cost savings
opportunities in the range of $150-$200 million across cost of goods sold,
general and administrative expenses, and inventory, and efforts are underway to
quickly capture value. Leveraging
ongoing improvements across our business, we are accelerating our path to
profitability, notably in our largest market, Canada."
Canopy
Rivers Inc. (TSX:
RIV)
(OTC:CNPOF) today
released its unaudited condensed interim consolidated financial
statements and management's discussion and analysis for the three and six
months ended September 30, 2020.
"Our quarter was framed with a
sharp focus on PharmHouse. We provided debtor-in-possession financing to enable
PharmHouse to remain operational as it commenced its CCAA process and our team
has been working towards securing the best possible outcome for our
shareholders," said Narbe Alexandrian, President and CEO, Canopy Rivers.
"While supporting PharmHouse has been our priority, we are confident we
will put this challenging situation behind us and remain encouraged by the
progress across our portfolio. This quarter, we participated in Headset's
bridge round as it continues to bring its industry-leading analytical tools to
new markets, High Beauty launched a new product line, and BioLumic's most
recent cannabis field trials showed promising gains in dried flower mass and
cannabinoid content."
"Most notably, the value of
TerrAscend's common shares increased by 101% during the quarter, and the implied
value of our investment in TerrAscend is now approximately $214 million,"
added Alexandrian. "After a U.S. election that potentially spells good
outcomes for the cannabis sector, including the legalization of adult-use
cannabis in New Jersey, we are pleased to have our U.S. exposure through our
holdings of exchangeable shares in one of the nation's leading multistate
operators. We believe that we will be well positioned to capitalize on
opportunities in the U.S. once we are permitted to do so."
Investors
can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
No comments:
Post a Comment